Fmr LLC Stoke Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 7,412,982 shares of STOK stock, worth $264 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,412,982

Previous 2,541,937 191.63%

Holding current value

$264 Million

Previous $16.9 Million 397.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.9 - $11.84 $28.7 Million - $57.7 Million	4,871,045 Added 191.63%	7,412,982 $84.1 Million
Q1 2025 May 12, 2025	BUY	$6.65 - $12.74 $15.8 Million - $30.3 Million	2,376,741 Added 1438.74%	2,541,937 $16.9 Million
Q4 2024 Feb 13, 2025	SELL	$10.8 - $13.92 $1.7 Million - $2.2 Million	-157,753 Reduced 48.85%	165,196 $1.82 Million
Q3 2024 Nov 13, 2024	SELL	$12.24 - $15.92 $918,856 - $1.2 Million	-75,070 Reduced 18.86%	322,949 $3.97 Million
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $248,594 - $394,865	22,538 Added 6.0%	398,019 $5.38 Million
Q1 2024 May 13, 2024	BUY	$4.12 - $14.17 $1.53 Million - $5.25 Million	370,481 Added 7409.62%	375,481 $5.07 Million
Q4 2023 Feb 13, 2024	BUY	$3.37 - $5.4 $4,286 - $6,868	1,272 Added 34.12%	5,000 $26,000
Q3 2023 Nov 13, 2023	SELL	$3.78 - $11.99 $8.78 Million - $27.8 Million	-2,321,757 Reduced 99.84%	3,728 $14,000
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $2.83 Million - $4.94 Million	357,274 Added 18.15%	2,325,485 $24.7 Million
Q1 2023 May 11, 2023	SELL	$7.65 - $10.38 $8.16 Million - $11.1 Million	-1,066,438 Reduced 35.14%	1,968,211 $16.4 Million
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $1.05 Million - $2.32 Million	-147,854 Reduced 4.65%	3,034,649 $28 Million
Q3 2022 Nov 10, 2022	BUY	$12.56 - $22.53 $2.73 Million - $4.9 Million	217,515 Added 7.34%	3,182,503 $40.9 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $1.96 Million - $4.53 Million	189,406 Added 6.82%	2,964,988 $39.2 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $3.8 Million - $5.76 Million	220,783 Added 8.64%	2,775,582 $58.4 Million
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $1.85 Million - $3.13 Million	101,928 Added 4.16%	2,554,799 $61.3 Million
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $7.6 Million - $11.1 Million	321,415 Added 15.08%	2,452,871 $62.4 Million
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $65.1 Million - $87.6 Million	2,131,456 New	2,131,456 $71.7 Million

Others Institutions Holding STOK

# of Institutions

138

Shares Held

58M

Call Options Held

2.7K

Put Options Held

57.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.4B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account